Report
Fact-based, data-driven research and analysis to advance democratic debate on vital issues shaping people’s lives.
Center for Economic and Policy Research
1611 Connecticut Ave. NW
Suite 400
Washington, DC 20009
Tel: 202-293-5380
Fax: 202-588-1356
https://cepr.net
November 2004, Dean Baker
This study’s projections show that all states would see substantial savings under the Free Market Drug Act, a proposal to directly fund drug research and allow all new drugs to be sold as generics. The biggest winners would be New York, California and Texas. Over the years 2009 to 2013, these states would save $9.3 billion, $7.1 billion, and $3.7 billion, respectively.